ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

DEST Destiny Pharma Plc

18.00
-0.25 (-1.37%)
07 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Destiny Pharma Plc LSE:DEST London Ordinary Share GB00BDHSP575 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -1.37% 18.00 17.50 18.50 18.25 18.00 18.25 225,759 15:40:10
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -6.5M -0.0683 -2.64 17.15M
Destiny Pharma Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker DEST. The last closing price for Destiny Pharma was 18.25p. Over the last year, Destiny Pharma shares have traded in a share price range of 13.50p to 83.00p.

Destiny Pharma currently has 95,271,863 shares in issue. The market capitalisation of Destiny Pharma is £17.15 million. Destiny Pharma has a price to earnings ratio (PE ratio) of -2.64.

Destiny Pharma Share Discussion Threads

Showing 2826 to 2848 of 2900 messages
Chat Pages: 116  115  114  113  112  111  110  109  108  107  106  105  Older
DateSubjectAuthorDiscuss
12/4/2024
10:16
henley2 agreed: and they were much heralded on return and arrival respectively.
carlisle44
12/4/2024
10:13
Will dip my toe in at 10p
the codger
12/4/2024
08:54
I cannot see this going private based on the current share register. Henley is spot on with his post regarding the treatment of shareholders but this is AIM and rarely do these people get any admonishment for their lack of care for those that pay their outlandish salaries and perks.
marvelman
12/4/2024
08:45
You either sell up, or if you can remain an investor in an unquoted company.
You have to wonder wtf Rudd and Tovey are up to and why the Nomad is not forcing them to make a statement regarding the share price movement!

henley2
12/4/2024
08:39
Question :-

As the chatter regarding the de-listing from AIM is now rise.

What will happen to the existing shareholder in case of de-listing ? I guess Management will offer a price and we are forced to take it ?

Thoughts ?

eva_1989
12/4/2024
08:34
Well here comes sub 20P

Adding more..

eva_1989
11/4/2024
18:36
Oh dear another biotech struggling after shoeing it's some way off and likely to need more funding. Given how far away this is I'm not surprised to see it falling eseoxailly now John Henry has bought. Will be suspended next lol.macd just turned negative again even after 2 days of falls. Chartooks horrific a bit like John's face lol
bones698
11/4/2024
17:40
Richard Henry ? Pips
pippa pinkerton
11/4/2024
16:43
May I suggest you do some research into the companies that are listing and who has a big influence within that company? I'll give you a clue first name Richard.
john henry
11/4/2024
16:23
Think they may follow etx and delist
bimbamboom
11/4/2024
11:52
Eva PA certainly behaving like a possible fund raise doing the rounds however there has been a large seller for months so maybe today they throw the towel in and clear.
john henry
11/4/2024
11:48
Added further today..

Fund raise indeed coming but r/r is high considering 1+ year hold

Will add further sub 20p if i get.

Building position now

eva_1989
11/4/2024
11:47
Dipped a toe back in a tad under 21p, have been out of these for a while but with the Mkt Cap dipping below £20M seems good Med term value.
john henry
11/4/2024
09:49
Oh dear John Henry still. Backing losers are you. Told you it was heading south. Not sure why you referenced AGL at me all my shares there are totally free thanks
bones698
10/4/2024
23:50
Don’t worry, brooko said this was undervalued at 80p, what a prat
ttlance
10/4/2024
15:29
The CEO's decision to push reformulation of M3 to the point where a rerun of Phase 2 may be required continues to look inexplicable. The emphasis on exploring all options to optimise value in recent RNS' does hint a going private as a possibility but their share holder register, with no large 10%+ holdings, might make getting support for it problematic. Once xf-73 dermal gets into Phase 1 for diabetic ulcers and burns things will look a bit better.

ODT have been pusing their (very decent) tech for 10 years or more with neglible revs and no cash plus a similar burn rate to DEST. Neither co looks a good buy at the moment imo. Not clear whether either co can attract someone to fund a US P3 trial. Dest are at least in talks, ODT don't seem to be.

banshee
10/4/2024
13:09
Certainly does if Steriwave has the same kill % as XF73
Which it appears too,

john henry
10/4/2024
12:35
Thanks martinrai1950. Looks bad news for XF73.
jias
10/4/2024
08:30
Spot on Henley imho over the next few years the UK will lose a complete sector in Biotech/Tech.
john henry
10/4/2024
07:43
E-Therapeutics the next company going private.
Reading their RNS tells you everything that is wrong with the AIM market.
Destiny next?

henley2
09/4/2024
16:03
And what of Sir Nigel thus far?
carlisle44
09/4/2024
10:29
More interested in announcement of deals they are negotiating.
New CEO was praised but so far achieved nothing.
Except crashing share price.IMHO

mam fach
08/4/2024
17:22
Hopefully someone will ask at the Investor Meet whether or not there is a chance of this going private???? With REDX in mind!
wh1spa
Chat Pages: 116  115  114  113  112  111  110  109  108  107  106  105  Older

Your Recent History

Delayed Upgrade Clock